Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News Briefs: Medtronic’s CoreValve Approval; J&J Dx Unit Set For Sale; Google’s Glucometer Contact Lens

This article was originally published in The Gray Sheet

Executive Summary

Medtronic gains FDA approval for its transcather CoreValve system months earlier than predicted. The Carlyle Group makes binding offer for J&J’s Ortho-Clinical Diagnostics business. Google is developing a wireless glucometer embedded within a contact lens. More news briefs.


Related Content

Google Parent Spins Off Firm With Medical Device-Focused Pipeline
People Briefs: JenaValve CEO; Ortho-Clinical Changes; Baxter CFOs
Edwards Wins Latest Round In TAVI Patent Dispute With Medtronic
Digital Health Briefs: Google Visits CDRH; IBM Watson Business; ZioPatch Data
News Briefs: Lung Screening Recs; Stryker Purchase; CMS News
Lotus Launches In Europe: Boston Scientific Joins Crowded TAVR Field
Medtronic CoreValve Meets Targets In Extreme-Risk Group; Panel Will Not Be Needed, FDA Says
Class Act: Status Of CDRH’s 515 Initiative
J&J Considers Sale, Spin-Off For Ortho-Clinical Diagnostics
AF Ablation: Surgery And Catheter Techniques Both Shine At AHA


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts